Cargando...
Lupus anticoagulant and mortality in patients hospitalized for COVID-19
Coronavirus disease 2019 (COVID-19) is characterized by a procoagulant state that can lead to fatal thromboembolic events. Several studies have documented a high prevalence of lupus anticoagulant that may at least partially explain the procoagulant profile of COVID-19. However, the association betwe...
Gardado en:
| Publicado en: | J Thromb Thrombolysis |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Springer US
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7648549/ https://ncbi.nlm.nih.gov/pubmed/33159639 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11239-020-02335-w |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|